# Q-linea

其 ASTar 系统直接从阳性血培养样本运行快速表型抗生素药敏检测，该公司近期宣布 ASTar 血液检测扩展菜单获得 FDA 批准，扩大了该平台的抗生素与病原体覆盖范围。

Source: https://cn.bioecon.ru/companies/q-linea/
Updated: 2026-07-20

- 国家: Sweden

## 可核验事实

| 事实 | 数值 | 来源 |
| --- | --- | --- |
| 融资 | SEK 3.12亿配股于2025年11月完成 | https://qlinea.com/0986741_wp-uploads/2026/05/Qlinea_2025_ENG.pdf, https://qlinea.com/mfn_news/year-end-report-1-january-31-december-2025/ |
| 产能 | 耗材生产内部化及抗生素灌装/干燥工艺提升了生产产能 | https://qlinea.com/0986741_wp-uploads/2026/05/Qlinea_2025_ENG.pdf |
| 认证 | ASTar仪器及耗材的CE-IVDR认证 | https://qlinea.com/0986741_wp-uploads/2026/05/Qlinea_2025_ENG.pdf, https://storage.mfn.se/c3f795b4-c8ad-4188-9f3f-d6f4f952ceab/qlinea-2024-eng.pdf |
| 监管批准 | ASTar系统获FDA 510(k)许可(2024年4月),并于2026年4月扩展革兰氏阴性血培养菜单 | https://qlinea.com/0986741_wp-uploads/2026/05/Qlinea_2025_ENG.pdf, https://qlinea.com/mfn_news/q-linea-announces-fda-clearance-of-expanded-astar-blood-testing-menu/, https://storage.mfn.se/c3f795b4-c8ad-4188-9f3f-d6f4f952ceab/qlinea-2024-eng.pdf |
| 生产基地 | 位于瑞典乌普萨拉Palmbladsgatan的耗材生产场所 | https://qlinea.com/0986741_wp-uploads/2026/05/Qlinea_2025_ENG.pdf |
| 员工人数 | 截至2026年6月30日为70名员工 | https://stockanalysis.com/quote/sto/QLINEA/employees/ |
| 营收 | 2025全年为15.29M瑞典克朗 | https://stockanalysis.com/quote/sto/QLINEA/revenue/ |

独立来源: stockanalysis.com, storage.mfn.se

## 技术

- [快速抗生素耐药性检测](https://cn.bioecon.ru/technology/rapid-antibiotic-resistance-tests/)